Understanding Lupus Anticoagulant (dRVVT) Screen (LA 1) Ratio: Normal vs Optimal Ranges

?What is Lupus Anticoagulant (dRVVT) Screen (LA 1) Ratio?

The lupus anticoagulant (LA) dRVVT screen measures the ratio between test and control phospholipid-dependent clotting times to detect the presence of antiphospholipid antibodies. The dilute Russell Viper Venom Time (dRVVT) is a sensitive confirmatory test used when LA is suspected based on prolonged activated partial thromboplastin time (aPTT). An elevated ratio may suggest the presence of lupus anticoagulant, which paradoxically increases thrombotic risk despite its anticoagulant activity in vitro.

!Why It Matters

Detection of lupus anticoagulant is important because it is associated with an increased risk of blood clots (thrombosis) and pregnancy complications, even though it has an anticoagulant effect in laboratory testing. A positive LA result can be associated with antiphospholipid syndrome, autoimmune conditions like systemic lupus erythematosus, or acquired thrombophilia, and may warrant anticoagulation therapy or additional monitoring depending on clinical context.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Recurrent blood clots (deep vein thrombosis or pulmonary embolism)
• Recurrent pregnancy loss or miscarriage
• Prolonged bleeding time or easy bruising
• Stroke or transient ischemic attack
• Thrombotic events without obvious cause

How to Improve Your Levels

• 1Consult a hematologist or thrombosis specialist for risk stratification and management planning
• 2Consider anticoagulation therapy if clinically indicated based on thrombotic history
• 3Maintain adequate hydration to support healthy circulation
• 4Avoid prolonged immobilization; maintain regular physical activity as tolerated
• 5Monitor for symptoms of thrombosis and seek immediate medical attention if chest pain, leg swelling, or neurological symptoms develop
• 6If pregnant or planning pregnancy, discuss thromboprophylaxis options with your obstetrician

When to Test

Testing is indicated when there is a prolonged aPTT that does not correct with normal plasma mixing study, clinical suspicion of antiphospholipid syndrome, history of unexplained thrombosis, recurrent pregnancy loss, or family history of thrombotic disorders. Repeat testing may be performed 12 weeks after an initial positive result to confirm persistent positivity, as acute infections or medications can transiently elevate LA levels.

Related Biomarkers